Puri Tipu S, Quigg Richard J
Section of Nephrology, University of Chicago, Chicago, IL 60637, USA.
Semin Nephrol. 2007 May;27(3):321-37. doi: 10.1016/j.semnephrol.2007.02.005.
The complement system is an important component of the innate immune system and a modulator of adaptive immunity. The entire complement system is focused on C3 and C5. Thus, there are proteins that activate C3 and C5, those that regulate this activation, and those that transduce the effects of C3 and C5 activation products; each can affect the kidney in renal injury. The normal kidney has the inherent capacity to protect itself from complement activation through cellular expression of decay-accelerating factor, membrane cofactor protein (in human beings), and Crry (in rodents). In addition, plasma factor H protects vascular spaces in the kidney. Although the main function of these proteins is to limit complement activation, there is now considerable evidence that they can transduce signals on engagement in immune cells. The G-protein-coupled 7-span transmembrane receptors for C3a and C5a, and the integral membrane complement receptors (CR) for C3b, iC3b, and C3dg, are expressed outside the kidney, particularly in cells of hematopoietic and immune lineage. These are important in renal injury through their infiltration of the kidney and/or by affecting kidney-directed immune responses. There is mounting evidence that intrinsic glomerular and tubular cell C3aR and C5aR expression and activation also can affect renal injury. CR1 on podocytes and the beta2 integrins CR3 and CR4 in kidney dendritic cells have functions that remain poorly defined. Cells of the kidney also have the capacity to produce and activate their own complement proteins. Thus, intrinsic renal cells express decay-accelerating factor, membrane cofactor protein, Crry, C3aR, C5aR, CR1, CR3, and CR4. These can be engaged by C3 and C5 activation products derived from systemic and local pools in renal injury. Given their capacity to provide signals that influence kidney cellular behavior, their activation can have substantial effects in renal injury. Defining these in a cell- and disease-specific fashion is an exciting challenge for future research.
补体系统是固有免疫系统的重要组成部分,也是适应性免疫的调节因子。整个补体系统主要围绕C3和C5展开。因此,存在激活C3和C5的蛋白质、调节这种激活的蛋白质以及转导C3和C5激活产物效应的蛋白质;每种蛋白质都可在肾损伤中影响肾脏。正常肾脏具有通过细胞表达衰变加速因子、膜辅因子蛋白(人类)和Crry(啮齿动物)来保护自身免受补体激活的内在能力。此外,血浆中的因子H可保护肾脏中的血管腔。尽管这些蛋白质的主要功能是限制补体激活,但现在有大量证据表明它们在与免疫细胞结合时可转导信号。C3a和C5a的G蛋白偶联7跨膜受体以及C3b、iC3b和C3dg的整合膜补体受体(CR)在肾脏外表达,特别是在造血和免疫谱系的细胞中。它们通过浸润肾脏和/或影响针对肾脏的免疫反应,在肾损伤中发挥重要作用。越来越多的证据表明,肾小球和肾小管细胞内源性C3aR和C5aR的表达及激活也可影响肾损伤。足细胞上的CR1以及肾树突状细胞中的β2整合素CR3和CR4的功能仍不清楚。肾脏细胞也有能力产生并激活自身的补体蛋白。因此,肾内细胞表达衰变加速因子、膜辅因子蛋白、Crry、C3aR、C5aR、CR1、CR3和CR4。在肾损伤中,这些蛋白可被源自全身和局部池的C3和C5激活产物所作用。鉴于它们具有提供影响肾脏细胞行为信号的能力,其激活在肾损伤中可产生重大影响。以细胞和疾病特异性的方式明确这些影响是未来研究中一项令人兴奋的挑战。